Hypoglycemia is common and dangerous in diabetes mellitus, so identifying at-risk patients may lead to useful preventive strategies. This Regenstrief-Merck partnership aims to design a risk calculator to aid clinicians in identifying at-risk patients who may benefit from preventive strategies. The project team members will conduct a retrospective cohort analysis, focus-group discussions, use of a new computer-based risk-prediction tool, and assessment of processes and outcomes associated with usage of the tool among healthcare providers.
-
Research
- Experts
In The News
View AllAP News features LOINC
LOINC, developed and maintained by the Regenstrief Institute, was featured by AP...
Influence
View AllOffice of Strategic Innovation helps connect startups with research expertise
Moving healthcare innovations from promising ideas to real-world impact requires...
- About
Regenstrief is dedicated to pioneering transformative solutions for a healthier world.
- The Latest
- Collaboration
Generating Evidence Across the Full Arc of Disease
Regenstrief Institute x Merck The Question Clinical trials establish whether...
Evaluating AI-Enabled Trial Screening in Real-World Oncology Workflows
Regenstrief, Triomics and Indiana University Health, supported by an independent...
- Experts




